Pills on top of coin stacks, piggy (Photo: Shutterstock)

A pharmaceutical industry association on Tuesday filed a legal challenge to the Trump Administration’s prescription drug rebate rule, which would replace the current drug rebate model with one that passes savings directly on to consumers.

The lawsuit by the Pharmaceutical Care Management Association (PCMA), filed in the district court for the District of Columbia, asks the court to set aside the rebate rule under the Administrative Procedure Act. The lawsuit also includes a request for a declaration from the court that federal law protects the rebates that Office of Inspector General, U.S. Department of Health and Human Services, is seeking to remove from the discount safe harbor regulation.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.